Thomas Appio

Insider Reports History

Reporting-owner location: Bridgewater, NJ
Latest reporting-owner signature: /s/ Brianna M. Dorsi attorney-in-fact
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas Appio

Form 4 holding Chief Executive Officer, Director

Bausch Health Companies Inc.

Security class: Common Shares, No Par Value
Shares / value: 2,315,374
Estimated value: $13,776,475
Report date: 02 Mar 2026
Price: $5.95
Ownership: Direct

Insider Reports Filed by Thomas Appio

4 BHC

Bausch Health Companies Inc.

Report period: 27 Feb 2026
Transactions: 3
Transaction value: -$7,761,065
Accepted by SEC: 03 Mar 2026, 17:41
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 25 Feb 2026
Transactions: 2
Transaction value: -$703,672
Accepted by SEC: 27 Feb 2026, 17:12
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 09 Feb 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 11 Feb 2026, 18:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 28 Feb 2025
Transactions: 3
Transaction value: -$1,538,957
Accepted by SEC: 03 Mar 2025, 16:07
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 26 Feb 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 Feb 2025, 16:39
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 30 Aug 2024
Transactions: 1
Transaction value: -$87,070
Accepted by SEC: 03 Sep 2024, 16:21
Role: Chief Executive Officer, Director
Next action: Open filing details

4/A BHC

Bausch Health Companies Inc.

Report period: 29 Feb 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jun 2024, 16:45
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 29 Feb 2024
Transactions: 5
Transaction value: -$1,156,952
Accepted by SEC: 04 Mar 2024, 16:19
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 01 Sep 2023
Transactions: 1
Transaction value: -$119,379
Accepted by SEC: 05 Sep 2023, 17:09
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 02 Mar 2023
Transactions: 6
Transaction value: -$254,449
Accepted by SEC: 06 Mar 2023, 15:49
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 27 Feb 2023
Transactions: 2
Transaction value: -$60,549
Accepted by SEC: 01 Mar 2023, 16:43
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 01 Sep 2022
Transactions: 1
Transaction value: -$101,414
Accepted by SEC: 02 Sep 2022, 16:35
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 10 May 2022
Transactions: 6
Transaction value: -$301,007
Accepted by SEC: 12 May 2022, 20:44
Role: Chief Executive Officer, Director
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 03 Mar 2022
Transactions: 1
Transaction value: -$131,366
Accepted by SEC: 07 Mar 2022, 16:30
Role: CEO, Pharma Business
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 02 Mar 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 04 Mar 2022, 15:50
Role: CEO, Pharma Business
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 26 Feb 2022
Transactions: 6
Transaction value: -$917,216
Accepted by SEC: 02 Mar 2022, 20:12
Role: CEO, Pharma Business
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 15 Dec 2021
Transactions: 1
Transaction value: -$84,760
Accepted by SEC: 30 Dec 2021, 18:29
Role: CEO, Pharma Business
Next action: Open filing details

4 BHC

Bausch Health Companies Inc.

Report period: 01 Sep 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 03 Sep 2021, 16:09
Role: Pres&Co-Head Bausch&Lomb/Int'l
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .